Bradley J. Turner

9.7k citations

95 papers · 4.0k indexed · h-index 36

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 58
- Parkinson's Disease Mechanisms and Treatments 18
Genetics top 0.5%
- Neurogenetic and Muscular Disorders Research 40
Neurology top 1%
- Amyotrophic Lateral Sclerosis Research 58
- Parkinson's Disease Mechanisms and Treatments 18
Cellular and Molecular Neuroscience top 5%
- Nerve injury and regeneration 7
Molecular Biology top 5%
- RNA Interference and Gene Delivery 8
Physiology
- Alzheimer's disease research and treatments 11
Epidemiology
- Autophagy in Disease and Therapy 9
Biomaterials
- biodegradable polymer synthesis and properties 7

Co-authors: Kevin Talbot Nirma D. Perera Julie D. Atkin Surindar S. Cheema Elizabeth C. Lopes Andrew F. Hill Justin J. Yerbury Malcolm Horne
Cited by: Neurology Genetics
Journals: Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Bradley J. Turner

92 papers receiving 3.9k citations

Peers

Countries citing papers authored by Bradley J. Turner

Since Specialization

Citations

This map shows the geographic impact of Bradley J. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley J. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley J. Turner more than expected).

Fields of papers citing papers by Bradley J. Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley J. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley J. Turner. The network helps show where Bradley J. Turner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bradley J. Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bradley J. Turner Line = papers co-authored together Bradley J. Turner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice Progress in Neurobiology ·Mouna Haidar,Aida Viden,Clément Daniel,Brittany Cuic,Taide Wang,Marius Rosier,Doris Tomas,Samuel A. Mills,A. Cole,Elvan Djouma,Nirma D. Perera,Sophia J. Luikinga,Valeria Rytova,Samantha K. Barton,David G. Gonsalvez,Lucy M. Palmer,Catriona McLean,Matthew C Kiernan,Steve Vucic,Bradley J. Turner	2025	0
2	The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis International Journal of Molecular Sciences ·Elisa Teyssou,Laura Chartier,Delphine Roussel,Nirma D. Perera,Ivan Nemazanyy,Dominique Langui,Mélanie Albert,Thierry Larmonier,Safaa Saker,François Salachas,Pierre‐François Pradat,Vincent Meininger,Philippe Ravassard,Francine Côté,Christian S. Lobsiger,Séverine Boillée,Bradley J. Turner,Danielle Seilhean,Stéphanie Millecamps	2022	12
3	Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS Neuroscience Letters ·Steve Vucic,Nathan Pavey,Mouna Haidar,Bradley J. Turner,Matthew C. Kiernan	2021	32
4	The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice Purinergic Signalling ·Diane Ly,Anjila Dongol,Peter Cuthbertson,Thomas V. Guy,Nicholas J. Geraghty,Reece A. Sophocleous,Lucia Sin,Bradley J. Turner,Debbie Watson,Justin J. Yerbury,Ronald Sluyter	2020	26
5	Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS Cell Death and Differentiation ·Taide Wang,Nirma D. Perera,Mathew D. F. Chiam,Brittany Cuic,Nayomi Wanniarachchillage,Doris Tomas,André L. Samson,Wayne Cawthorne,Eric N. Valor,James M. Murphy,Bradley J. Turner	2019	59
6	Transactive Response DNA-Binding Protein 43 Abnormalities after Traumatic Brain Injury Journal of Neurotrauma ·Xin Tan,Mujun Sun,Rhys D. Brady,Shijie Liu,Roxana M. Llanos,Steve Cheung,David Wright,Pablo M. Casillas‐Espinosa,Maithili Sashindranath,Terence J. O’Brien,Stuart J. McDonald,Bradley J. Turner,Sandy R. Shultz	2018	24
7	Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways Cellular and Molecular Neurobiology ·Judith M. Silverman,Sarah Fernando,Leslie I. Grad,Andrew F. Hill,Bradley J. Turner,Justin J. Yerbury,Neil R. Cashman	2016	79
8	Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice Human Molecular Genetics ·Nirma D. Perera,Rebecca K. Sheean,Peter J. Crouch,Anthony R. White,Malcolm Horne,Bradley J. Turner	2016	19
9	Diverse Roles for Wnt7a in Ventral Midbrain Neurogenesis and Dopaminergic Axon Morphogenesis Stem Cells and Development ·Chathurini V. Fernando,Julianna Kele,Christopher R. Bye,Jonathan C. Niclis,Walaa F. Alsanie,Brette Blakely,Jan M. Stenman,Bradley J. Turner,Clare L. Parish	2014	25
10	The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass The Journal of Cell Biology ·Catherine E. Winbanks,Justin L. Chen,Hongwei Qian,Yingying Liu,Bianca C. Bernardo,Claudia Beyer,Kevin I. Watt,Rachel E. Thomson,Timothy Connor,Bradley J. Turner,Julie R. McMullen,Lars Larsson,Sean L. McGee,Craig A. Harrison,Paul Gregorevic	2013	168
11	Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice Neurobiology of Aging ·Bradley J. Turner,Neza Alfazema,Rebecca K. Sheean,James N. Sleigh,Kay E. Davies,Malcolm Horne,Kevin Talbot	2013	35
12	Motor neuron diseases : causes, classification, and treatments Bradley J. Turner,Julie D. Atkin	2012	2
13	HspB8 mutation causing hereditary distal motor neuropathy impairs lysosomal delivery of autophagosomes Journal of Neurochemistry ·Alice S. Kwok,Kanchan Phadwal,Bradley J. Turner,Peter L. Oliver,Annie Raw,Anna Katharina Simon,Kevin Talbot,Vishwas R. Agashe	2011	47
14	Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model Neurobiology of Disease ·Bradley J. Turner,Nick Parkinson,Kay E. Davies,Kevin Talbot	2009	56
15	TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy BMC Neuroscience ·Bradley J. Turner,Dirk Bäumer,Nick Parkinson,Jakub Scaber,Olaf Ansorge,Kevin Talbot	2008	53
16	Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis Journal of Neuroscience ·Bradley J. Turner,Julie D. Atkin,Manal A. Farg,Da Wei Zang,Alan Rembach,Elizabeth C. Lopes,Justin D. Patch,Andrew F. Hill,Surindar S. Cheema	2005	154
17	The β‐amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane Journal of Neurochemistry ·Su San Mok,Dušan Lošić,Colin J. Barrow,Bradley J. Turner,Colin L. Masters,Lisandra L. Martin,David H. Small	2005	30
18	Chemotherapy Delays Progression of Motor Neuron Disease in the SOD1 G93A Transgenic Mouse Chemotherapy ·Kimberli Bruce,Kailash Narayan,Hui Kong,Ian Larmour,Elizabeth C. Lopes,Bradley J. Turner,John F. Bertram,Surindar S. Cheema	2004	5
19	Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS Journal of Neuroscience Research ·Alan Rembach,Bradley J. Turner,Stephen J. Bruce,Irwin K. Cheah,Rachel Scott,Elizabeth C. Lopes,Chrissandra J. Zagami,Philip M. Beart,Nam Sang Cheung,Steven J. Langford,Surindar S. Cheema	2004	57
20	Antisense peptide nucleic acid‐mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice Journal of Neurochemistry ·Bradley J. Turner,Irwin K. Cheah,Katherine J. Macfarlane,Elizabeth C. Lopes,Steven Petratos,Steven J. Langford,Surindar S. Cheema	2003	79

About Bradley J. Turner

Bradley J. Turner is a scholar working on Neurology, Genetics and Neurology, having authored 95 papers that have together received 4.0k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (58 papers), Neurogenetic and Muscular Disorders Research (40 papers), Parkinson's Disease Mechanisms and Treatments (18 papers), Alzheimer's disease research and treatments (11 papers), Autophagy in Disease and Therapy (9 papers), RNA Interference and Gene Delivery (8 papers), Nerve injury and regeneration (7 papers) and biodegradable polymer synthesis and properties (7 papers). The work is most often cited by research in Neurology (1.9k citations), Genetics (1.2k citations) and Neurology (529 citations). Bradley J. Turner has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kevin Talbot, Nirma D. Perera, Julie D. Atkin, Surindar S. Cheema, Elizabeth C. Lopes, Andrew F. Hill, Justin J. Yerbury, Malcolm Horne, Manal A. Farg and Neil R. Cashman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact